Research: All Articles
Anzanello, Michel J., et al. “A framework for selecting analytical techniques in profiling authentic and counterfeit Viagra and Cialis.” Forensic Science International 235, (February 2014): 1-7.
AbstractSeveral analytical techniques aimed at profiling drugs are deemed costly and time consuming, and may not be promptly available for analysis when required. This paper proposes a method for identifying the analytical techniques providing the most relevant data for classification of drug samples into authentic and unauthentic categories. For that matter, we integrate principal components…
[...]Anzanello, Michel J., et al. “A multivariate-based wavenumber selection method for classifying medicines into authentic or counterfeit classes.” Journal Of Pharmaceutical & Biomedical Analysis 83, (September 2013): 209-214.
Highlights We propose a wavenumber selection framework based on a wavenumber importance index. The method increases classification performance using a small wavenumber range. Our propositions are applied to Cialis and Viagra FTIR-ATR data. Abstract Attenuated total reflectance (ATR), a sampling technique by Fourier transform infrared (FTIR) spectroscopy, has been adopted as an analytical tool for…
[...]Dégardin, Klara, Yves Roggo, and Pierre Margot. “Understanding and fighting the medicine counterfeit market.” Journal Of Pharmaceutical & Biomedical Analysis 87, (January 18, 2014): 167-175.
Abstract Medicine counterfeiting is a serious worldwide issue, involving networks of manufacture and distribution that are an integral part of industrialized organized crime. Despite the potentially devastating health repercussions involved, legal sanctions are often inappropriate or simply not applied. The difficulty in agreeing on a definition of counterfeiting, the huge profits made by the counterfeiters…
[...]da Justa Neves, Diana Brito, Ravane Gracy Ament Marcheti, and Eloisa Dutra Caldas. “Incidence of anabolic steroid counterfeiting in Brazil.” Forensic Science International 228, no. 1-3 (May 10, 2013): e81-e83.
AbstractThis retrospective study reports data obtained from the National Institute of Criminalistics of the Brazilian Federal Police Department (DPF) on 3676 anabolic products seized between 2006 and 2011. Anabolic androgenic steroids (AAS) were declared on the labels of 96.2% of the products. About one third of the products declared to be from Paraguay, and 14.3%…
[...]“Operation Pangea VI: combating sale of unapproved medicines.” WHO Drug Information 27, no. 3 (September 2013): 227.
Abstract: The article reports on a 2013 decision which the U.S. Food and Drug Administration and several other international law enforcement and regulatory agencies made to take legal and regulatory action against more than 9,600 web sites from various countries that illegally market unproven prescription drugs to consumers. "Operation Pangea VI: combating sale of unapproved…
[...]Ganor, Boaz, and Miri Halperin Wernli. “The Infiltration of Terrorist Organizations Into the Pharmaceutical Industry: Hezbollah as a Case Study.” Studies In Conflict & Terrorism 36, no. 9 (September 2013): 699-712.
Abstract: Criminal syndicates and terrorist organizations are inherently different, one motivated by profit and the other by political goals. Yet their difference enables them to cooperate for their mutual benefit. Nowhere has this been more evident than in the drug trade; from harvesting and trafficking in illegal substances, it has been an easy transition to counterfeiting…
[...]Mackey, Tim K.*, and Bryan A. Liang*. “Pharmaceutical digital marketing and governance: illicit actors and challenges to global patient safety and public health.” Globalization & Health 9, no. 1 (November 2013): 1-21.
BackgroundDigital forms of direct-to-consumer pharmaceutical marketing (eDTCA) have globalized in an era of free and open information exchange. Yet, the unregulated expansion of eDTCA has resulted in unaddressed global public health threats. Specifically, illicit online pharmacies are engaged in the sale of purportedly safe, legitimate product that may in fact be counterfeit or substandard. These…
[...]Glass, Beverley D. “Counterfeit drugs and medical devices in developing countries.” Research & Reports In Tropical Medicine 5, (March 2014): 11-22.
Abstract: The World Health Organization has reported that counterfeit medicines potentially make up more than 50% of the global drug market, with a significant proportion of these fake products being encountered in developing countries. This occurrence is attributed to a lack of effective regulation and a weak enforcement capacity existing in these countries, with an…
[...]Binkowska-Bury, Monika, et al. “Counterfeit medicines in Poland: opinions of primary healthcare physicians, nurses and lay persons.” Journal Of Clinical Nursing 22, no. 3/4 (February 2013): 559-568.
Aims and objectives. To gain information concerning disparities in the understanding of the counterfeit medicines phenomenon between healthcare workers and lay persons. Background. Central-eastern Europe is facing significant challenges in combating a multi-billion euro, and often lethal, trade in counterfeit medicines. It is a major challenge especially for primary healthcare workers to expand the understanding…
[...]Nemlekar P, Shepherd M*, Lawson K, and Rush S. Web-Based Survey to Assess the Perceptions of Managed Care Organization Representatives on Use of Copay Subsidy Coupons for Prescription Drugs. J Manag Care Pharm. 2013;19(8):602-08.
ABSTRACT BACKGROUND: Promotion of prescription drug coupons and vouchers by pharmaceutical manufacturers has increased in recent years. These coupons and vouchers usually subsidize patients’ cost-sharing obligations. In other words, drug companies pay for a patient’s portion of the drug cost, and the remaining cost is paid by the patient and the patient’s health plan. This…
[...]